Gagliardi Monica, Annesi Grazia, Tarantino Patrizia, Nicoletti Giuseppe, Quattrone Aldo
Section of Neuroimaging, Institute of Molecular Bioimaging and Physiology, National Research Council, Catanzaro, Italy.
Section of Neuroimaging, Institute of Molecular Bioimaging and Physiology, National Research Council, Catanzaro, Italy.
Neurobiol Aging. 2014 Oct;35(10):2422.e1-2. doi: 10.1016/j.neurobiolaging.2014.04.020. Epub 2014 Apr 26.
Parkinson's disease (PD) is characterized by progressive loss of dopaminergic neurons in the substantia nigra pars compacta. This degeneration leads to bradykinesia, muscular rigidity, resting tremor, and postural instability. It affects 1%-2% of the population above the age of 60 years. Recently, 2 studies identified the Asp620Asn mutation in the vacuolar protein sorting 35 (VPS35) gene, and the Arg1205His in the eukaryotic translation initiation factor 4 gamma 1 gene (EIF4G1) were reported to be associated an autosomal dominant form of PD. In this study we screened these mutations in a cohort of 250 South Italy patients with familial PD and 250 control subjects from South Italy. VPS35 Asp620Asn mutation and EIF4G1 Arg1205His mutation were not found in our 250 PD patients. This result, with our previous reports on the absence of mutations in LRRK2 and in SNCA, warrant a continuing search for novel causative genes for PD among South Italy.
帕金森病(PD)的特征是黑质致密部多巴胺能神经元进行性丧失。这种退化导致运动迟缓、肌肉僵硬、静止性震颤和姿势不稳。它影响60岁以上人群的1%-2%。最近,两项研究在液泡蛋白分选35(VPS35)基因中鉴定出Asp620Asn突变,据报道真核翻译起始因子4γ1基因(EIF4G1)中的Arg1205His与常染色体显性形式的PD相关。在本研究中,我们在一组250名意大利南部家族性PD患者和250名意大利南部对照受试者中筛查了这些突变。在我们的250名PD患者中未发现VPS35 Asp620Asn突变和EIF4G1 Arg1205His突变。这一结果,结合我们之前关于LRRK2和SNCA无突变的报道,保证了在意大利南部继续寻找PD的新致病基因。